SCHEMBL6172373

SCHEMBL6172373

CCOC(=O)c1cc(C(=O)c2[nH]c3ccc(Cl)cc3c2C(C)C(=O)O)on1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
CYP1A2 P05177 1/20 0.48
HPGD P15428 1/20 0.48
XBP1 P17861 1/20 0.48
CYP2C19 P33261 1/20 0.48
GAA P10253 1/20 0.47
MAPT P10636 3/20 0.46
CSF1R P07333 1/20 0.44
PTGS2 P35354 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ABCC4 O15439 1/20 0.43
C5 P01031 1/20 0.43
PTGS1 P23219 1/20 0.43
PDE4D Q08499 1/20 0.43
ALOX15 P16050 7/20 0.41
TUBB4A P04350 1/20 0.41
TUBB P07437 1/20 0.41
TUBA3C P0DPH7 1/20 0.41
TUBA1B P68363 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170020 0.83 PTGS2 (0.50) ALDH1A1CYP1A2HPGDXBP1CYP2C19
SCHEMBL7202069 0.83 PTGS2 (0.41) ALDH1A1CYP1A2HPGDXBP1CYP2C19
SCHEMBL7202070 0.81 KDM4E (0.44) ALDH1A1CYP1A2HPGDXBP1CYP2C19
SCHEMBL6171377 0.80 PTGS2 (0.49) ALDH1A1CYP1A2HPGDXBP1CYP2C19
SCHEMBL27540484 0.80 GAA (0.49) ALDH1A1CYP1A2HPGDXBP1CYP2C19
SCHEMBL6171752 0.77 PTGS2 (0.49) ALDH1A1CYP1A2HPGDXBP1CYP2C19
SCHEMBL6171197 0.74 PTGS2 (0.49) ALDH1A1CYP1A2HPGDXBP1CYP2C19
SCHEMBL6173187 0.74 PTGS2 (0.51) ALDH1A1MAPTPTGS2MEN1KMT2A
SCHEMBL6173791 0.74 PTGS2 (0.51) ALDH1A1MAPTPTGS2MEN1KMT2A
SCHEMBL6171454 0.74 PTGS2 (0.44) ALDH1A1MAPTPTGS2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP claimed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US claimed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed